 Using World health organization criteria, almost there was equal prevalence of ischemic and hemorrhagic stroke  the most complication developed was brain edema in about one third of patient  More than half of the patients had at least one past medication and anti-hypertensive were the commonly used prestroke medications.
Introduction
As per World Health Organization (WHO) criteria, stroke is a rapidly developing clinical signs of focal or global disturbance of cerebral function, with symptoms lasting 24 hours or longer or leading to death, with no apparent cause other than vascular origin [1, 2] . As heart disease and stroke statistics of 2016 report from American Heart Association (AHA), stroke was the second-leading global cause of death behind heart disease in 2013, accounting for 11.8% of total deaths [3] . Unlike in developing countries, stroke mortality has been declining since the early 20 th century, fallen from the third to the fourth leading cause of death in the United States due to major improvement in population health by reducing stroke risks, mostly improved control of hypertension [4] .
There were differences in the prevalence of major risk factors among the stroke subtypes, demonstrating that knowledge of pathophysiology is essential for the proper management of these patients [5] . The American heart/ stroke association recommends tissue plasminogen activator, antiplatelet (aspirin, clopidogrel), anticoagulants (heparin, warfarin), antihypertensive and lipidlowering agents for the treatment if ischemic stroke whereas osmotherapy, neuromuscular relaxants, neuroprotection and neuro-restoration therapy, reperfusion therapy and calcium channel blockers for hemorrhagic stroke [6] . In resource-limited settings without access to neuroimaging, administration of aspirin to all patients presenting with acute stroke of undetermined etiology for the period of initial hospitalization could result in improved outcomes at hospital discharge [7] .
The number of stroke patients receiving r-tPA in the developing world is extremely low. Prehospital delay, financial constraints, and lack of infrastructure are main barriers of thrombolytic therapy in developing countries [8] . This is because of the fact that thrombolytic therapy has been proven to be beneficial if drugs are only administered within 4.5 hours after the onset of an ischemic stroke. In Ethiopia significant delays during the pre-hospital or in-hospital phases of care augmented by insufficient management of cases in the country is also making prognosis of stoke patients very poor [9] .
Stroke is currently observed to be one of the commonest reasons of admission in many hospitals and becoming an increasingly serious public health issue in Ethiopia [10, 11] . Under-diagnosing of hypertension and other risk factors and delayed presentation at the hospital are the major challenges
to address [10] . As patients usually present late and the standard of care is poor compared to hospitals in developed countries, the in hospital mortality is expected to be higher [11] .
In Ethiopia, patients with stroke are often poorly managed and discharged from hospital without receiving adequate rehabilitation services. This has a series implication in terms of saving the life of patients especially with hemorrhagic stokes which are characterized by sever neurologic presentation [9] . Like other developing countries resources for stroke care and rehabilitation are deficient in Ethiopia [9] . The paucity of data specific to the Ethiopian setting is limiting the formulation of an appropriate response [10] . Hence this study will generate evidences for improving the management of stroke and guide health authorities to halt or reduce the burden of stoke at different sectors of the community.
Patients and Methods
The study was conducted at stroke unit of Jimma university medical center (JUMC), a tertiary hospital found in Jimma city, south-west Ethiopia, which is 352 kilometers from Addis Ababa. It is the main referral center for neurology patients in south west Ethiopia. Stroke unit of JUMC was established with assistance of project from United Kingdom aid direct (UKAID) and tropical health and education
Trust (THET) with help of Southampton hospital in 2015. Prospective observational study design was carried out for consecutive 4 months from March 10-July 10, 2017
All 116 patients > 18 years having either clinical diagnosis or confirmed by imaging as per WHO criteria for diagnosis of stroke and admitted to stroke unit of JUMC within the study period were included. Patient or guardian not willing to give an informed consent, those who died before evaluation by stroke neurologist/ other physician as well as after further evaluation if initial diagnosis of stroke was later changed to other case (ruled out stroke) as long as the patient was in the stroke unit were excluded from the study.
Data collection tool and procedure
Data collection was carried out by two Bachelor of Science (BSc) nurses and one internal medicine resident with training on the contents of data collection tool. Data collectors collect all relevant data from the patients chart and interview using a prepared data extraction form. The needed history used for the study was taken from the patient and/or relatives in the language they understood.
Controversial data was discussed with stroke physicians working in the stroke unit of JUMC during
study period. Data collection tool include Sociodemographic, encountered complications and management approaches of stroke patients.
Data processing and analysis
Checked data was cleaned and entered to Epidata version 3.1 and analyzed using statistical package for the social sciences (SPSS) for windows version 20. Descriptive statistics were calculated to describe the Sociodemographic characteristics, encountered complications and time to start of medications. Chi-square (χ2) test was used to test the significance of associations between categorical variables and Kolmogorov-Smirnov test was used to assess the distribution of variables. Predictors with probability value less than 0.05 was considered statistically significant.
Ethics approval and consent to participate
Ethical clearance was obtained from the Institutional Review Board (IRB) of Jimma University, Institute of health. Verbal consent was obtained from responsible bodies of the hospital and stroke unit of the hospital prior to the interview and reviews of the patient data. At hospital from patients written consent was obtained. All patients got the right to opt out of the research. The data from the case records and interview was handled with strong confidentiality. The confidentiality and privacy of patients was assured throughout by removing identifiers from data collection tools using different codes.
Result
Using WHO criteria from 116 included study participants, 60 (51.7%) patients had ischemic stroke while 56 (48.3%) had hemorrhagic stroke.
Sociodemographic characteristics of the patients
The mean age of the patients was 55.14+14.04 years. Males comprised of 73 (62.9%) with male:
female ratio of 1.70:1. Majority of the participants had informal education (able to read and write) 49 (42.2%) followed by no basic education (unable to write and read) 42.2%. As per to this finding none of the sociodemographic factors have association with stroke based on chi-square result (P >0.05).
In hospital complication of stroke
During the hospital admission a total 93 (80.2%) [IS=44 and HS= 49] patients had developed at least one complication. Neurologic complication were statistically significant in hemorrhagic stroke compared to ischemic stroke patients (P<0.01). In general neurological complication developed in 53 Common neurologic complication developed was brain edema / increase in intracranial pressure which was occurred in about one third of patient (30.2 %) followed by swallowing difficulties/dysphagia 13 (11.2%) and epileptic seizure 10 (8.6 %). Brain edema was statistically significant complication in hemorrhagic stroke as compared to ischemic stroke (p<0.001).
Additionally swallowing difficulties and intracranial hemorrhage were prominent in HS but other neurologic complications like epileptic seizure, recurrent stroke and delirium were prominent in ischemic stroke but not statistically significant. Most medical complication developed during the study period was urinary incontinence 33 (28.4%) followed by aspiration pneumonia 23(19.8%) and electrolyte disturbance 20 (17.2%). Urinary incontinence, aspiration pneumonia and electrolyte disturbance were higher in HS but other medical complications were more prevalent in ischemic stroke without statistical difference (Table 2 ).
Approaches / protocols of stroke management
Of the total patients included in the study, 61 (52.5%) had at least one past medication. The most prestroke medications were diuretics 33 (54.1%) followed by angiotensin converting enzyme inhibitors 
Discussion
In this study setup complications were prevalent in majority of the stroke patients (80.2% ), due severity of the disease itself, associated comorbidities and set up of the hospital for the management of emergency chronic conditions associated with shortage of appropriate laboratories, equipment's, medications and skilled man power. The most complication developed during the study period was brain edema / increased intracranial pressure followed by urinary incontinence and aspiration
pneumonia, these complications especially brain edema and aspiration pneumonias were the common complications in consistent to other findings [10] [11] [12] [13] .
Unlike our finding, urinary tract infection was the commonest and pneumonia was less as study by
Deleu et al in Arabian Gulf countries [14] . Aspiration pneumonia followed by urinary tract infection was the most common complications developed as per study by Mamushet et al Ethiopia [15] . In this study electrolyte abnormalities was one major complication similar to study by Jia et al in Fujian [12] . This variety of complications in different setup at different times may be related to study design, type of stroke, comorbidities and hospital service.
Complications after stroke were common and major factors contributing to mortality. Being aware of the types of common complications and associated risk factors helps the clinical team involved in the care of stroke patients to make preparations and plans for the best possible care and to take preventive measures. This will save a lot of lives with best possible use of meager resources available such as educating the population to avoid oral feeding for patients with altered mental state and physicians to evaluate gag reflex bedside swallowing test and proper positioning of patients to avoid aspiration pneumonia [15] , appropriate treatment of brain edema with drugs like mannitol and appropriate catheterization of the patient for urinary incontinence is necessary.
More than half of the patients had at least one past medication, mostly for the treatment of comorbidities like diabetes mellitus, hypertension and heart failure. Anti-hypertensive were the commonly used prestroke medications as majority of the patients had previous history of hypertension. During hospitalization majority of the patients (95.7%) had received at least one medication. Medications were given during hospitalization for the treatment of ischemic stroke, underlying conditions and common complications. Time to start of medication depends on the condition of the patient, type of stroke, imaging result, laboratory parameters and complications developed. During hospitalization the most common medication given for the patient was antiplatelets and statins mostly for ischemic stroke 63 (54.3%), similar to others studies as the most well studied treatments for ischemic stroke is antiplatelets and statins [16] . As a class the most commonly prescribed drugs were antihypertensive, finding in line with other studies in which hypertension was the commonest risk factor for stroke [6, 13] .
In this study 7 patients with hemorrhagic stroke (6.0%) received antiplatelets wrongly before stroke was confirmed by imaging suspecting clinically to be ischemic stroke. This abnormality is due to the
fact that brain imaging is malfunction or not done at all if patients or their attendants are not convinced of the benefit of the CT scan, or they are not willing or able to pay initially that delays the imaging.
In these cases, physicians sometimes give anticoagulants and antiplatelets if the patient is suspected of having ischemic stroke. When imaging result becomes available either through negotiation or when the CT scan function, these medications were immediately stopped if the patient is found to have hemorrhagic stroke contrary to the preliminary suspected diagnosis of ischemia. This highlights that despite the availability of the CT scan, educational level and economic capacity remain as major barriers to utilization of this important diagnostic tool among stroke patients. During discharge about two third (67.2%) of the patients had received medication and antihypertensive were the prominent medications for discharge given for half of the total patients. At discharge, antiplatelet medication and lipid lowering medication were more commonly provided to patients with ischemic strokes than those with hemorrhagic strokes [16, 17] . This was consistent with our study that at discharge antiplatelets and statins were given for 49 (42.2%) patients with ischemic strokes alone.
Strength and limitations of the study
The major strength of this study was its prospective study design and the enrollment of consecutive patients. This prospective study allowed collection of accurate data on Sociodemographic, complications and treatments approaches. Hence, the study can inform stroke management strategies and interventions required to decrease mortality associated with stroke. The weakness of the study was first it was a hospital-based study rather than population based, hence may be subjected to referral
bias. Additionally, the sample size was small hampering the analysis of some prognostic indicators due to the short recruitment period.
Conclusion
Both neurologic and medical complications were common in majority of the patients, due to severity of the disease itself, associated comorbidities and set up of the hospital. The most complication developed during the study period was brain edema / increased intracranial pressure followed by urinary incontinence and aspiration pneumonia. More than half of the patients had at least one past medication and anti-hypertensive were the commonly used prestroke medications. During hospitalization majority of the patients had received at least one medication, from those about one third of them received within 3 hours of hospital arrival. The most common medication given during hospitalization was antiplatelets and statins mostly for ischemic stroke. During discharge about two third of the patients had received medication and anti-hypertensive were the prominent medications for discharge given for half of the total patients.
Involvement of community and faith-based organizations, emphasis on examination to differentiate between hemorrhagic and ischemic stroke and training of community health professionals on essential management of stroke should be urgently implemented. By being aware of the types of common complications and associated risk factors, the clinical team involved in the care of stroke patients should make preparations and plans for the best possible care and to take preventive measures that will save a lot of lives. We recognize that in our hospital, the management protocol for stroke patients is sub-optimal and lagging behind the recommended guidelines due to lack of appropriate treatment and diagnostic agent for etiologic investigation in addition to trained man power. In addition, the ministry of health of the country should develop and implement generalized protocol guideline for in hospital management and post stroke follow-up. There is burning need to establish and strength the available stroke unit which are well-equipped and staffed intensive care units in different hospitals across the country for proper stroke care, to reduce stroke mortality and post stroke disability. 
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